Monte Rosa Therapeutics, Inc.

GLUE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$12.60-0.40%

2026-09-17

Financials

Valuation Metrics

Monte Rosa Therapeutics, Inc.'s Market Cap is $1.06B. At end of 2025 it was $1.03B. Ranked #2441 of 3,121 in US market (top 78%), #991 of 1,463 on NASDAQ (top 68%), #184 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 69%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$1.06B	US#2,441/3,121 Sec#184/266
Revenue	$29M	US#2,811/3,121 Sec#161/266
Net Income	$-161M	US—/3,121 Sec—/266
Total Assets	$696M	US#2,636/3,121 Sec#133/266
Net Assets	$487M	US#2,250/3,121 Sec#110/266
Value
P/B	2.18x	US#1,357/3,121 Sec#58/266
P/S	37.05x	US#2,899/3,121 Sec#159/266
FCF Yield	-6.70%	US—/3,121 Sec—/266
Profitability
ROE	-33.06%	US#2,590/3,121 Sec#121/266
ROA	-23.15%	US#2,835/3,121 Sec#138/266
Op. Margin	-633.04%	US#2,814/3,121 Sec#159/266
Revenue Growth	-83.86%	US#2,766/3,121 Sec#179/266
Earnings Growth	-766.65%	US#2,027/3,121 Sec#69/266
Financial Health
Debt Ratio	43.31%	US#489/3,121 Sec#134/266
Total Debt	$38M	US#2,661/3,121 Sec#167/266
FCF	$-71M	US#2,578/3,121 Sec#125/266
Cash	$90M	US#2,286/3,121 Sec#184/266
Current Ratio	9.52x	US#273/3,121 Sec#85/266
Performance
1Y Return	98.11%	US#227/3,121 Sec#65/266
1M Return	-16.17%	US#2,861/3,121 Sec#225/266
From 52W High	-51.11%	US#2,751/3,121 Sec#219/266
1Y MDD	-50.22%	US#2,473/3,121 Sec#181/266
Trading
Volume	1,248,139 shares	US#1,208/3,121 Sec#125/266
Trading Value	$16M	US#2,054/3,121 Sec#161/266
Per Share
EPS	$-1.91	US—/3,121 Sec—/266
BPS	$5.77	US#2,220/3,121 Sec#119/266